Fundraising Fox

Simbryotech

Houston, US · Founded 2023 · 1 known investors

Find your way into Simbryotech

Simbryo Technologies is a biotech company that creates endometrial organoids from a patient's own stem cells using a routine biopsy, offering functional diagnostic tests of the uterine lining to assess and optimize endometrial fertility. Working with research institutions and fertility clinics, it uses organoid medicine and AI to give patients and physicians insights aimed at improving IVF success rates and to serve as a test bed for new fertility treatments.

AI & Machine LearningBiotechDigital HealthFemTechMedical Devices

Founders & leadership

YKYael Katz
Yael KatzinFounder & CEOExecutive Officer, Director at BrainCheck
AW
Aryeh WarmflashNamed on SEC filing
SR
Stephen RooksNamed on SEC filing
AMAndrea Mazzocchi
Andrea MazzocchiinBoard MemberCo-founder, PhD at Known Medicine

Investors · 1

TSVCSilicon Valley · $1M

Reported raises · per SEC filings

Form D private placements

$5.3M disclosed across 1 of 2 rounds · 2025–2026

▶$5.3MraisedJul 2026 · 24 investors · Biotechnology
Rule 506(b)
Simbryo discloses $5.25M round for organoid-based fertility diagnostics - RuntimeWireruntimewire.com · Jul 2026Texas Weekly Deal Highlightstexasceomagazine.com · Aug 2026
Officers, directors & promoters on the filing
  • Yael KatzExecutive Officer, Director
  • Aryeh WarmflashExecutive Officer
  • Stephen RooksDirector
  • Andrea MazzocchiDirector
Offering amount
$5.3M
Amount sold
$5.3M
First sale
Sep 2025
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Simbryotech went on to found or lead other companies.

Andrea MazzocchiBoard MemberFounded Play Health +1Yael KatzFounder & CEOFounded BrainCheck

Competitors · 5

by search overlap
Zibrio4 shared keywordsZIBRIO develops a balance assessment technology using machine learning to measure postural stability through a one-minute standing test, designed for both self-administration and clinical settings to identify fall risk in older adults. The company serves healthcare providers and older adults seeking fall prevention and balance monitoring.
Los Angeles Project4 shared keywordsBuilding.life uses genetic engineering, genomic analysis, and AI to design novel organisms, beginning with engineering the world's first true unicorn through precision gene editing and embryonic development.
Pano AI3 shared keywordsPano develops artificial intelligence and machine learning technology solutions to help utility companies and fire agencies detect and manage wildfire threats. The company serves emergency managers and professionals in the utility and fire industries seeking to protect communities from wildfires.
Simbiosys3 shared keywordsSimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning. Its tools serve breast cancer surgeons and clinicians for preoperative planning and analysis in oncology.
Insitro3 shared keywordsinsitro is a drug discovery and development company that uses machine learning and cellular data to identify therapeutic insights and accelerate the creation of new medicines. The company serves patients and pharmaceutical development by integrating in vitro lab data with human clinical data to decode biology and unlock transformative treatments.

Companies competing with Simbryotech for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Texas Weekly Deal Highlightstexasceomagazine.com · Aug 2026Simbryo discloses $5.25M round for organoid-based fertility diagnostics - RuntimeWireruntimewire.com · Jul 2026

Frequently asked questions

What does Simbryotech do?
Simbryo Technologies is a biotech company that creates endometrial organoids from a patient's own stem cells using a routine biopsy, offering functional diagnostic tests of the uterine lining to assess and optimize endometrial fertility. Working with research institutions and fertility clinics, it uses organoid medicine and AI to give patients and physicians insights aimed at improving IVF success rates and to serve as a test bed for new fertility treatments.
Who are Simbryotech's investors?
Simbryotech's investors include TSVC.
How much funding has Simbryotech raised?
Simbryotech has disclosed $5.3M raised across 1 of its 2 known rounds.
Where is Simbryotech headquartered?
Simbryotech is headquartered in Houston, US.